Georg Nickenig

Georg Nickenig

Interventional cardiologist / Cardiologist
UKB Universitätsklinikum Bonn - Bonn, Germany

Latest contributions

Updates in tricuspid interventions: from the procedure to follow-up

15 Apr 2025

Register for free to this webinar on 6 May at 5:00pm (UTC+2) with G. Nickenig, J. Dreyfus, S. Kar and P. Lurz and learn about the follow-up results of the TRILUMINATE trial, and so much more!

Transcatheter mitral intervention for failed surgical valves and rings - The toolkit

26 Nov 2024 – From PCR London Valves 2024

Looking to enhance your approach to failed surgical mitral valves and rings? This video is a must-watch!

You’ll explore patient selection, master the steps of mitral valve-in-valve and valve-in-ring procedures, and learn strategies like valve cracking and LAMPOON to overcome key challenges. 

Transcatheter mitral intervention for failed surgical valves and rings - The toolkit

Recurrent and residual tricuspid regurgitation after transcatheter repair - Assessment and management

26 Nov 2024 – From PCR London Valves 2024

Join us as we delve into the critical topic of recurrent and residual tricuspid regurgitation after transcatheter repair. Gain valuable insights on how to avoid these complications, learn to assess the underlying mechanisms and severity, and explore the latest options for interventional treatment. This session, developed...

Recurrent and residual TR after transcatheter repair - Assessment and management

Advanced imaging in tricuspid TEER - LIVE case

26 Nov 2024 – From PCR London Valves 2024

Watch a LIVE case followed by a recorded case on how to use imaging in tricuspid TEER:

  • A 64-year-old male with a history of CABG and COPD, ICD implantation (2013) mitraclip (2018) and poor LV function (25%), presented a torrential functional tricuspid regurgitation. The operators implanted 2...
Advanced imaging in tricuspid TEER - LIVE case

RESHAPING the transcatheter treatment of mitral and tricuspid regurgitation

25 Nov 2024 – From PCR London Valves 2024

Join this compelling session focused on the transcatheter treatment of mitral and tricuspid regurgitation. Explore detailed case discussions, including a mitral regurgitation case, a challenging MitraClip procedure, and a severe tricuspid regurgitation case. Discover key takeaways from the RESHAPE, MATTERHORN, and Tri.FR trials, and learn how...

RESHAPING the transcatheter treatment of mitral and tricuspid regurgitation

Advanced mitral TEER - LIVE case

24 Nov 2024 – From PCR London Valves 2024

Join us for a LIVE case followed by a recorded case highlighting advanced treatments for severe secondary mitral regurgitation:

  • A 75-year-old man with permanent AF, a history of CABG, and symptomatic severe secondary MR (atrial and ischemic causes) with low LV function (45%) underwent mitral repair with...
Advanced mitral TEER - LIVE case

Innovation never stops: Cardiovalve in action!

24 Nov 2024 – From PCR London Valves 2024

Join us as we explore the latest advancements in transcatheter tricuspid valve replacement technologies. This session develops the anatomical and imaging challenges associated with this rapidly developing clinical field and provides an update on the Cardiovalve tricuspid clinical program, illustrated by a recorded case.

Innovation never stops: Cardiovalve in action!

PCR Tricuspid Focus Group - referral meeting in Bonn

13 Jun 2024

Join your peers for this meeting on 24 January 2025 in Bonn, Germany!

To repair or to replace the mitral valve: that is the question

16 May 2024 – From EuroPCR 2024

This session provides a comprehensive understanding of both transcatheter edge-to-edge repair (TEER) and transcatheter mitral valve replacement (TMVR) techniques, including their respective advantages, suitability criteria, and clinical outcomes. The session features insights from a surgeon's perspective on the considerations and techniques involved in mitral valve repair...

To repair or to replace the mitral valve: that is the question

Clinical outcomes of transcatheter mitral and tricuspid valve repair and replacement

15 May 2024 – From EuroPCR 2024

Clinical outcomes of transcatheter mitral and tricuspid valve repair and replacement

TAVI updates: expanding indications

14 May 2024 – From EuroPCR 2024

This session presents the latest updates and evidence on the expanding indications for transcatheter aortic valve implantation (TAVI). It covers topics such as the impact of unfavorable aortic valve anatomy on TAVI outcomes, sex-specific differences in cardiac damage in aortic stenosis patients undergoing TAVI, the use...

TAVI updates: expanding indications

Transcatheter tricuspid valve intervention - Too many patients, too little evidence

21 Nov 2023 – From PCR London Valves 2023

Watch this tricuspid valve session to explore the evolution of transcatheter tricuspid intervention, from a once deemed crazy concept to an everyday procedure. Reflect on the choice between replacement and repair for the tricuspid valve and understand the necessity of a multidisciplinary approach, uniting specialists in...

Transcatheter tricuspid valve intervention - Too many patients, too little evidence

Tricuspid transcatheter valve replacement: Cardiovalve keeps things in motion

20 Nov 2023 – From PCR London Valves 2023

Participate in this session to stay informed about the latest advancements in TTVR, receive updates on the Cardiovalve tricuspid program, and gain insights into how imaging demonstrates the concept underlying Cardiovalve transcatheter valve replacement technology.

Tricuspid transcatheter valve replacement: Cardiovalve keeps things in motion

New devices for tricuspid valve intervention

20 Nov 2023 – From PCR London Valves 2023

Join this session for a quick overview of groundbreaking devices shaping tricuspid valve interventions: witness the first-in-man experience with a cross-caval device designed for the treatment of tricuspid regurgitation, navigate through a challenging case involving a patient with massive tricuspid regurgitation and a permanent pacemaker lead and...

New devices for tricuspid valve intervention

The Top Late-Breaking Trials: TRISCEND II, TRILUMINATE at 3 years, EuroSMR score, CLASP IID, OPERA-TAVI...

19 Nov 2023 – From PCR London Valves 2023

Discover the top late-breaking trials which were presented during PCR London Valves 2023:

  • TRISCEND II: A randomised trial of transcatheter tricuspid valve replacement vs medical therapy
  • Percutaneous edge-to-edge repair for tricuspid regurgitation: TRILUMINATE trial three-year outcomes
  • Transcatheter mitral valve-in-valve vs. redo surgical replacement for degenerated bioprostheses
  • Artificial intelligence derived risk...
PCR London Valves 2023 Top Late-Breaking Trials

Controversies in atrioventricular valves - The Heart Team ring, Vol II

19 Nov 2023 – From PCR London Valves 2023

This session offers an opportunity to engage in a real case discussion led by an advanced Heart Team. Participate in discussions on controversial decision-making scenarios and stay informed about the latest clinical evidence related to MitraClip, Tendyne, and TriClip therapies.

Controversies in atrioventricular valves

Knocking mitral regurgitation down to improve outcomes: earlier is better, but better late than never! (Episode 2: the left side)

18 May 2023 – From EuroPCR 2023

Help optimize your patients' prognosis by attending this session! You'll learn how proper patient selection and timely interventions lead to lasting results and how to use the latest real-world registry data to gain insight into the safety and effectiveness of M TEER.

Valvular heart disease: novel transcatheter approaches

18 May 2023 – From EuroPCR 2023

Explore this thrilling session on transcatheter approaches for valvular heart disease, featuring the latest advancements, emerging techniques, and revolutionary research. Join your peer as they present novel strategies and devices aimed at improving valvular disease management.

Valvular heart disease: novel transcatheter approaches

Management of tricuspid valve regurgitation

11 Dec 2022

Watch the replay of the 2nd webinar on Tricuspid valve disease: patient pathways. You’ll learn all about 'Management of tricuspid valve regurgitation'

Transcatheter tricuspid valve intervention is booming: where are we now? and where are we going?

29 Nov 2022 – From PCR London Valves 2022

Watch these presentations to better understand what's happening in the field of tricuspid valve intervention and to appreciate the characteristics of current and newly emerging transcatheter devices.

Transcatheter tricuspid valve intervention is booming: where are we now? and where are we going?

A case-based tailored approach to the treatment of mitral valve disease: the Heart Team ring

28 Nov 2022 – From PCR London Valves 2022

Join an advanced Heart Team in a real case discussion to understand what "mitral valve complexity" really means and to learn how to optimise selection between repair and replacement options.

How to deal with residual or recurrent mitral regurgitation after failed surgical or transcatheter repair

28 Nov 2022 – From PCR London Valves 2022

Consul this session to learn more about the available treatment options after failed mitral surgical or transcatheter procedures, the factors that increase the likelihood of residual/recurrent mitral regurgitation, and more!

How to deal with residual or recurrent mitral regurgitation after failed surgical or transcatheter repair

The right valves for the right ventricle: Venus MedTech tricuspid and pulmonary replacement systems

27 Nov 2022 – From PCR London Valves 2022

In this session from PCR London Valves 2022, discover the new Venus MedTech technology for tricuspid and pulmonary valve replacement, and a review of the clinical indications, selection criteria and procedural details.

The right valves for the right ventricle: Venus MedTech tricuspid and pulmonary replacement systems

Mitral valve in mitral annular calcification (MAC) - Recorded case

27 Nov 2022 – From PCR London Valves 2022

A 53-year-old male with a history of SAVR (Perimount 23) 10 years ago and chest radiotherapy (lymphoma) presents a severe mitral stenosis (MAC) with preserved LV function and impaired RV function.
On sentinel cerebral protection, the operators perform a transseptal puncture with electrifying a non-stiff guide wire,...

Recorded case: Mitral valve in MAC

Tricuspid valve interventions: patient and device selection

09 Aug 2022

PCR Webinar on tricuspid valve disease with F. Maisano, R. von Bardeleben, J. L. Zamorano, J. Cavalcante, P. Lurz and G. Nickenig

Treating tricuspid regurgitation percutaneously: tools and impacts

19 May 2022 – From EuroPCR 2022

Discover the tools and impacts of treating tricuspid regurgitation percutaneously by watching the cases of valve replacement, valve-in-ring implantation, transcatheter edge-to-edge repair and many more.

Treating tricuspid regurgitation percutaneously: tools and impacts

TriClip therapy: here now, here to stay

19 May 2022 – From EuroPCR 2022

Discover how tricuspid clip dedicated therapy allows treating a broad range of anatomies through real-life cases. Also, learn about its real-world outcomes and the performance in different tricuspid regurgitation patient profiles.

Mitral valve-in-valve

18 May 2022 – From EuroPCR 2022

Follow LIVE this case presented by St Thomas' Hospital, London, UK, of a 73-year-old-male patient with a degenerated mitral bioprosthesis to be treated with a catheter-based approach to appreciate key steps in planning and performing transcatheter mitral ViV procedures, and discuss potential approaches to smaller valves...

Mitral valve-in-valve

Tricuspid valve disease: guidelines and beyond

23 Nov 2021 – From PCR London Valves 2021

Watch this PCR London Valves 2021 session to hear about the latest European guidelines on the management of tricuspid valve disease, understand the details behind these guidelines and how they compare with those elsewhere in the world, and, most importantly, find out how Heart Teams can translate...

Tricuspid valve disease: guidelines and beyond

Transcatheter tricuspid valve interventions: the future

23 Nov 2021 – From PCR London Valves 2021

In this PCR London Valves 2021 session, observe the case of an 84-year-old, not overweight, quite active, female patient with a past history of restrictive cardiomyopathy and permanent atrial fibrillation, who presented with worsening dyspnea and obvious clinical signs of right ventricular heart failure, and discuss the...

Transcatheter tricuspid valve interventions: the future